Bevacizumab and risk of arterial and venous thromboembolism in metastatic castration-resistant prostate cancer patients treated on Cancer and Leukemia Group B (CALGB) 90401 (Alliance)
- Citation:
- Cancer vol 121 (7) 1025-1031
- Year:
- 2015
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 4
- Parents:
- 2145
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, CA33601, U01 GM063340, CA47577, U01 GM061393, P30 CA006973, U10 CA180802, CA41287, U10 CA021115, U10 CA031946, U01GM61393, CA77651, U10 CA033601, CA180820, CA180802, CA60138, U10 CA180821, R01 CA161608, R25 CA174664, P30 CA008748, P30 CA076292, GM61390, U01 GM061390, U10 CA016116, U10 CA180882, U19 GM061390, U10 CA180820, U01 HG007437, U10 CA180838, CA21115, CA31946, CA16116
- Corr. Author:
- Authors:
- Jai N. Patel Chen Jiang Daniel L. Hertz Flora A. Mulkey Kouros Owzar Susan Halabi Mark J. Ratain Paula N. Friedman Eric J. Small Michael A. Carducci John F. Mahoney Michael J. Kelley Michael J. Morris William K. Kelly Howard L. McLeod
- Networks:
- CA824, LAPS-IL036, LAPS-IL057, LAPS-MD017, LAPS-MN026, LAPS-NC007, LAPS-NY016, NC002
- Study
- CALGB-90401
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- arterial, venous, thromboembolism, bevacizumab, prostate, cancer, risk